Entos Pharma awarded $5 million in NRC IRAP funding to conduct phase I Clinical trial of COVID-19 DNA vaccine
On Oct. 23, 2020, Entos Pharmaceuticals announced it was receiving advisory services and funding of up to $5…
Entos announced spin-off company Aegis Life to support global vaccine commercialization
On Oct. 15, 2020, Entos Pharmaceuticals announces that its San Diego-based spinout company Aegis Life, will pursuing U.S….
The Nobel Prize in Chemistry for 2020 was awarded to Emmanuelle Charpentier and Jennifer A Doudna
On Oct. 7, 2020, the Nobel Prize in Chemistry 2020 was awarded to Emmanuelle Charpentier and Jennifer Doudna…
Neandertal gene variant increases risk of severe Covid-19
On Sept. 30, 2020, researchers at the Karolinska Institutet in Sweden and the Max Planck Institute for Evolutionary…
Biotechnology | COVID-19 | FDA | Infectious Disease | Life Science News | NIH | Vaccine
INOVIO reported FDA partial clinical hold for planned phase 2/3 trial of COVID-19 vaccine candidate INO-4800
On Sept. 28, 2020, INOVIO announced the U.S. Food and Drug Administration (FDA) had notified the company that…
INOVIO added Thermo Fisher Scientific to global manufacturing consortium
On Sept. 8, 2020, INOVIO announced that Thermo Fisher Scientific, the world leader in serving science, had signed…
OraSure’s ORAcollect-RNA device Included in EUA granted to MiraDx for SARS-CoV-2 test
On Sept. 3, 2020, OraSure Technologies announced that its ORAcollect-ï¾·RNA (OR-100) collection device was included along with other…
Aegis Life launched to fight COVID-19 via DNA vaccines and therapeutics enabled by Fusogenix delivery technology
On Sept. 1, 2020, Entos Pharmaceuticals announce the launch of its San Diego-based spinout company Aegis Life, dedicated…
Codex DNA building worldï¾’s first vaccine printer and global vaccine network
On Aug. 25, 2020, Codex DNA announced critical advancements in its development of the Digital-to-Biological Converterï¾™ (DBC) platform….
Sorrento announced agreement to acquire SmartPharm and develop gene-encoded therapeutic antibodies for COVID-19 and cancer therapeutics
On Aug. 20, 2020, Sorrento Therapeutics and SmartPharm Therapeutics announced the signing of a merger agreement under which…
OraSure’s OMNIgene-ORAL device included in EUA granted to Clinical Reference Laboratory for self-collected SARS saliva test
On Jul. 31, 2020, OraSure Technologies announced that its OMNIgene-ORAL (OM-505) saliva collection device is included in the…
INOVIO’s COVID-19 DNA vaccine INO-4800 provided protection with memory immune responses In non-human primates challenged with SARS-CoV-2 virus
On Jul. 30, 2020, INOVIO announced that its COVID-19 DNA vaccine INO-4800 targeting SARS-CoV-2 was effective in protecting…
NIH-funded project created an encyclopedia detailing the inner workings of the human and mouse genomes
On Jul. 29, 2020, the Encyclopedia of DNA Elements (ENCODE) Project is a worldwide effort to understand how…
Codex DNA released new synthetic SARS-CoV-2 genome for COVID-19 vaccine and therapeutic research
On Jul. 16, 2020, Codex DNA announced the release of a new synthetic SARS-CoV-2 genome developed to accelerate…
NIH researchers generated complete human X chromosome sequence
On Jul. 14, 2020, researchers at the National Human Genome Research Institute (NHGRI), part of the NIIH, announced…
UC Berkeley launched trial of saliva test for COVID-19
On Jun. 30, 2020, scientists from the Innovative Genomics Institute (IGI) at the University of California Berkeley announced…
Entos announced selection of lead candidates for pan-Coronavirus Fusogenix DNA vaccine and $42 million award
On Jun. 25, 2020, Entos Pharmaceuticals announced the selection of two lead candidates for a pan-coronavirus Fusogenix DNA…
NIH-funded study linked endometriosis to DNA changes
On Jun. 17, 2020, DNA from uterine cells of women with endometriosis has different chemical modifications, compared to…
Largest catalog of human genetic diversity released
On Jun. 9, 2020, an international gnomAD team of over 100 scientists released its first set of discoveries…
Cytiva and Entos Pharmaceuticals work together to accelerate development of COVID19 vaccines
On Jun. 1, 2020, Entos Pharmaceuticals announced a partnership with Cytiva, formerly part of GE Healthcare Life Sciences….
INOVIO COVID-19 DNA vaccine INO-4800 demonstrated robust neutralizing antibody and T cell immune responses in preclinical models
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
Regeneron and Colorado Center for Personalized Medicine announced major new human genetics research collaboration
On May 11, 2020, Regeneron and the Colorado Center for Personalized Medicine (CCPM) at the University of Colorado…
The FDA issued EUA for first diagnostic test using at-home collection of saliva specimens
On May 8, 2020, the FDA issued an emergency use authorization (EUA) to Rutgers Clinical Genomics Laboratory for…
Biotechnology | COVID-19 | Life Science News | Nanotechnology | Pharmaceutical | Therapeutics | Vaccine
Entos Pharma partnered with Precision NanoSystems to enable scalable GMP manufacturing of Fusogenix DNA COVID-19 vaccine
On May 7, 2020, Entos Pharmaceuticals announced a partnership with PrecisionNanoSystems (PNI) to produce clinica lgrade vaccines and…
New freeze-resistant trichinella species discovered in wolverines
On May 6, 2020, the U.S. Dept. of Agriculture (USDA) announced that a new freeze-resistant Trichinella species had…
DNA Genotek’s ORAcollect RNA kit included in EUA granted to Biocerna SARS-CoV-2 test
On May 4, 2020, DNA Genotek, a subsidiary of OraSure Technologies, announced that its ORAcollect RNA kit (OR-100)…
INOVIO expanded manufacturing of COVID-19 DNA vaccine INO-4800 with new funding from CEPI
On Apr. 30, 2020, INOVIO announced an agreement to expand its manufacturing partnership with the German contract manufacturer…
Entos Pharmaceuticals partnered with EpiVax to develop a pan-Coronavirus DNA vaccine
On Apr. 28, 2020, Entos Pharmaceuticals announced a collaboration with EpiVax. This partnership combined the Entos Fusogenix DNA…
INOVIO completed enrollment in phase 1 U.S. trial of INO-4800 for COVID-19 DNA vaccine
On Apr. 28, 2020, INOVIO announced that its Phase 1 U.S. clinical trial for COVID-19 DNA vaccine INO-4800…
INOVIO and GeneOne reported positive phase 1/2a clinical data with DNA vaccine INO-4700 for MERS Coronavirus
On Apr. 28, 2020, INOVIO and GeneOne Life Science announced interim data through week 16 from a Phase…